Skip to content
Menu

Aspire Biopharma Holdings, Inc. ASBP

Full chart Compare
Set alert

Price alert · ASBP

All alert types
7.13 USD -0.41 (-5.44%)

Regular-session close

7.25 +0.12 +1.68%

After hours · Nov 20, 4:00 PM ET

7.10 Day range 8.12
4.65 52-week range 170.40
YTD
-95.50%
1 year
-93.94%

Revenue & Expenses

Revenue Profit Costs
Net Loss$24.48MCost of Revenue$6.32KExpenses$24.48MGross Loss$116Selling, General & Admin$18.43MResearch & Development$923.91KOther Expenses$5.13MRevenue$6.20K

Latest period ending Dec 31, 2025 · select a line to chart its full history

ASBP annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
6.20K0000
-1160000
-19.35M-1.21M-358.59K-596.49K-25.48K
-24.48M-1.31M-359.07K-597.12K-25.48K
-491.00-57.00-12.00132.00—
ASBP annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.00M3.63K11.17K380
1.31M147.99K46.17K22.54K293.22K
7.69M1.69M534.03K151.33K293.70K
5.18M1.27M360.64K27.97K238.60K
-6.38M-1.54M-487.86K-128.79K-475
ASBP annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-4.92M-265.19K11.14K-142.91K-238.60K
5.92M257.64K04.85M238.60K
1.00M-7.54K11.14K-185.46K0